Culwell Kelly

Track

Insider profile

Performance

Overall performance
3.3
Performance over holding periods
3.3
30 days 90 days 120 days
Average return 67% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
1 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Culwell Kelly's trades of Evofem Biosciences Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Planned sale
Price
451.41
Quantity 95,616 +36.5%
Value US$1,004,425
Transaction date
Planned sale
Price
115.04
Quantity 29,085 +26.0%
Value US$1,022,311
Transaction date
Purchase
Price
2.24
Quantity 3,000 +33.4%
Value US$6,720
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2020-05-01 2020-05-01
PlS Planned sale
25,299 -34.2%
378.34
US$3,108,878 		25,299 -34.2% 378.34 US$3,108,878
2020-05-01 2020-04-30
PlS Planned sale
95,616 +36.5%
451.41
US$1,004,425 		95,616 +36.5% 451.41 US$1,004,425
2020-02-21 2020-02-19
PlS Planned sale
29,085 +26.0%
115.04
US$1,022,311 		29,085 +26.0% 115.04 US$1,022,311
2018-08-20 2018-08-16
B Purchase
3,000 +33.4%
2.24
US$6,720 		3,000 +33.4% 2.24 US$6,720